Product image of Pantoprazol Stada (Pantoprazole Sodium Sesquihydrate) supplied by GNH India

Pantoprazol Stada

Active Ingredient:
Pantoprazole Sodium Sesquihydrate
Origin:
EU

Pantoprazol Stada (Pantoprazole Sodium Sesquihydrate)

Pantoprazole sodium sesquihydrate, the active ingredient in Pantoprazol Stada, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is prescribed for conditions such as gastro‑esophageal reflux disease, erosive esophagitis, Zollinger‑Ellison syndrome, and for preventing NSAID‑induced gastric ulcers.

GNH India supplies Pantoprazol Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory support and consistent product quality across global markets, and timely delivery.

Manufacturer / TM Owner

Stadapharm Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Pantoprazol Stada, a proton pump inhibitor, is used to manage disorders related to excess gastric acid.

  • Gastro‑esophageal reflux disease (GERD): alleviates heartburn and esophageal irritation.
  • Erosive esophagitis: promotes healing of acid‑induced esophageal lesions.
  • Zollinger‑Ellison syndrome: controls hypergastrinemia‑driven acid hypersecretion.
  • Prevention of NSAID‑induced gastric ulcers: reduces risk of ulcer formation in patients taking non‑steroidal anti‑inflammatory drugs.

How It Works

  • Pantoprazole sodium sesquihydrate irreversibly binds to the H+/K+ ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By inhibiting this final step of acid secretion, it markedly lowers both basal and stimulated gastric acid output, leading to increased gastric pH and allowing mucosal healing. This effect persists for up to 24 hours after a single dose, supporting once‑daily dosing in most therapeutic regimens.

Side Effects

Pantoprazol Stada may be associated with a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects

  • Headache: mild to moderate pain in the head region.
  • Diarrhea: loose, watery stools occurring intermittently.
  • Nausea: feeling of unease and urge to vomit.
  • Abdominal pain: discomfort or cramping in the stomach area.

Serious or Rare Side Effects

  • Acute interstitial nephritis: inflammation of kidney interstitium that may impair renal function.
  • Clostridioides difficile infection: severe colitis caused by bacterial overgrowth.
  • Severe allergic reactions (anaphylaxis, Stevens‑Johnson syndrome): potentially life‑threatening hypersensitivity requiring immediate medical attention.

Precautions & Warnings

When prescribing Pantoprazol Stada, clinicians should consider several precautionary measures to ensure safe use.

  • Assess renal function: adjust use in patients with severe renal impairment.
  • Monitor magnesium levels: prolonged therapy may lead to hypomagnesemia.
  • Evaluate for Helicobacter pylori infection: consider eradication therapy before long‑term use.
  • Use the lowest effective dose: limit duration to the shortest period necessary.
  • Avoid concomitant use with drugs that require gastric acidity for absorption unless clinically justified.
  • Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Avoid Interactions

Pantoprazol Stada can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid)

  • Ketoconazole (and other antifungal agents requiring acidic pH): reduced absorption and efficacy.
  • Atazanavir: decreased plasma concentrations, risking therapeutic failure.
  • Clopidogrel: diminished activation leading to reduced antiplatelet effect.

Moderate Interactions (Monitor Closely)

  • Warfarin: possible increase in INR; monitor coagulation parameters regularly.
  • Digoxin: increased serum levels; observe for signs of toxicity.
  • High‑dose methotrexate: reduced renal clearance; monitor methotrexate concentrations and renal function.

Frequently Asked Questions

Pantoprazol Stada contains pantoprazole, a proton pump inhibitor indicated for the treatment of gastro‑esophageal reflux disease (GERD), healing of erosive esophagitis, management of Zollinger‑Ellison syndrome, and for the prevention of gastric ulcers associated with long‑term NSAID therapy.

Pantoprazole irreversibly blocks the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the secretory surface of parietal cells. This inhibition stops the final step of acid production, markedly lowering gastric acidity and allowing damaged mucosa to heal.

The appropriate dose of Pantoprazol Stada is determined by the prescribing clinician based on the specific indication, patient characteristics, and treatment goals. Dosing regimens may vary, and the prescriber will provide individualized instructions.

Safety data for pantoprazole in pregnancy and lactation are limited, and the product does not have a definitive pregnancy category. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and under medical supervision.

To order Pantoprazol Stada, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Pantoprazol Stada is a proton pump inhibitor similar in efficacy to other agents such as omeprazole or esomeprazole. It offers a favorable drug‑interaction profile, particularly with medications metabolised by CYP2C19, and is often preferred when reduced interaction risk is a priority.

Pantoprazol Stada should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing in humid environments.

Pantoprazol Stada is administered orally. The tablet should be swallowed whole with a glass of water, preferably before a meal, unless the prescribing information advises otherwise. Do not crush, chew, or split the tablet unless instructed by a healthcare professional.

Serious adverse reactions, although rare, include acute interstitial nephritis, Clostridioides difficile‑associated colitis, and severe hypersensitivity reactions such as anaphylaxis or Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience unexplained kidney problems, persistent diarrhea, or signs of an allergic reaction.

Pantoprazol Stada is contraindicated in individuals with known hypersensitivity to pantoprazole or any component of the formulation. Caution is advised for patients with severe hepatic impairment, and it should be avoided in those requiring gastric acidity for drug absorption unless alternative strategies are employed.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Pantoprazole Sodium Sesquihydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT